Studies of Myo-inositol and Plasmalogen Metabolism in Rat Brain

Neurochemical Research

Volumn 29, Issue 4, 2004, Pages 843-855

  Hoffman Kuczynski, Beth ^a   Reo, Nicholas V ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Brain phospholipid metabolism; Myo inositol; Phosphatidylethanolamine plasmalogen

Indexed keywords

ETHANOLAMINE; INOSITOL; PHOSPHATIDYLETHANOLAMINE; PLASMALOGEN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; LIPID BRAIN LEVEL; LIPID COMPOSITION; MALE; MEMBRANE STRUCTURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPID METABOLISM; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; INOSITOL; MALE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PLASMALOGENS; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 1842454996     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000018859.23881.f9     Document Type: Article

References (40)

1. Paltauf, F. 1994. Ether lipids in biomembranes. Chem. Phys. Lipids 74:101-139.
2. Brosche, T. 1997. Plasmalogen phospholipids: Facts and theses to their antioxidative qualities. Arch. Gerontol. Geriatr. 25:73-81.
3. Brosche, T., and Platt, D. 1998. The biological significance of plasmalogens in defense against oxidative damage. Exp. Gerontol. 33:363-369.
4. Engelmann, B., Brautigam, C., and Thiery, J. 1994. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochem. Biophys. Res. Commun. 204: 1235-1242.
5. Hahnel, D., Beyer, K., and Engelmann, B. 1999. Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and α-tocopherol. Free Radic. Biol. Med. 27:1087-1094.
6. Hahnel, D., Huber, T., Kurze, V., Beyer, K., and Engelmann, B. 1999. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem. J. 340:377-383.
7. Khaselev, N., and Murphy, R. C. 1999. Susceptibility of plasmenyl glycerophosphoethanolamine lipids pertaining to oxidative degradation. Free Radic. Biol. Med. 26:275-284.
8. Reiss, D., Beyer, K., and Engelmann, B. 1997. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J. 323:807-814.
9. Sindelar P. J., G. Z., Dallner G., and Emster L. 1999. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26:318-324.
10. Vagnozzi, R., Tavazzi, B., Di Pierro, D., Giardina, B., Fraioli, B., Signoretti, S., Distefano, S., Galvano, M., and Lazzarino, G. 1997. Effects of increasing times of incomplete cerebral ischemia upon the energy state and lipid peroxidation in the rat. Exp. Brain Res. 134:230-241.
11. Fauconneau, B., Stadelmann-Ingrand, S., Favreliere, S., Baudouin, J., Renaud, L., Piriou, A., and Tallineau, C. 2001. Evidence against a major role of plasmalogens in the resistance of astrocytes in lactic acid-induced oxidative stress in vitro. Arch. Toxicol. 74:695-701.
12. Das, A. K., and Hajra, A. K. 1988. High incorporation of dietary 1-O-heptadecyl glycerol into tissue plasmalogens of young rats. FEBS Lett. 227:187-190.
13. Das, A. K., Holmes, R. D., Wilson, G. N., and Hajra, A. K. 1992. Dietry ether lipid incorporation into tissue plasmalogens of humans and rodents. Lipids 27:401-405.
14. +/myo-inositol cotransporter transcription in the brain of acute hypernaturemic rats. Mol. Brain Res. 40:64-70.
15. +/myo-inositol cotransporter mRNA in rat brain. Mol. Brain Res. 70:179-186.
16. Chang, L., Ernst, T., Poland, R. E., and Jenden, D. J. 1996. in vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci. 58:2049-2056.
17. Davanzo, P., Thomas, M. A., Yue, K., Oshiro, T., Belin, T., Strober, M., and McCracken, J. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24:359-369.
18. Levine, J., Rapaport, A., Lev, L., Bersudsky, Y., Kofman, O., Belmaker, R. H., Shapiro, J., and Agam, G. 1993. Inositol treatment raises CSF inositol levels. Brain Res. 627:168-170.
19. Pettegrew, J. W., Panchalingam, K., Levine, J., McClure, R. J., Gershon, S., and Yao, J. K. 2001. Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen. Biol. Psychiatry 49:444-453.
20. Farooqui, A. A., and Horrocks, L. A. 2001. Plasmalogens: Workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7:232-245.
21. Lee, T.-C. 1998. Biosynthesis and possible biological functions of plasmalogens. Biochim. Biophys. Acta 1394:129-145.
22. Polokoff, M. A., Wing, D. C., and Raetz, C. R. H. 1981. Isolation of somatic cell mutants defective in the biosynthesis of phosphatidylethanolamine. J. Biol. Chem. 256:7687-7690.
23. Tyagi, R. K., Azrad, A., Degani, H., and Salomon, Y. 1996. Simultaneous extraction of cellular lipids and water-soluble metabolites: Evaluation by NMR spectroscopy. Magn. Reson. Medi. 35:194-200.
24. Adinehzadeh, M., and Reo, N. V. 1998. Effects of peroxisome proliferators on rat liver phospholipids: Sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid. Chem. Res. Toxicol. 11:428-440.
25. 31P NMR of extracted phospholipids. J. Lipid Res. 29:679.
26. 31P chemical shifts and absolute quantification. Q. Magn. Res. Biol. Med. 3: 171-176.
27. 13C NMR spectroscopy. Biochim. Biophys. Acta 1580:171-188.
28. Horrocks, L. A., Toews, A. D., Thompson, D. K., and Chin, J. Y. 1975. Synthesis and turnover of brain phosphoglycerides: Results, methods of calculation and interpretation Pages 37-54, in Porcellait, G., Luigi, A., and Claudio, G., (Eds.), Vol. 72, Plenum Press, New York.
29. Diagne, A., Fauvel, J., Record, M., Chap, H., and Douste-Blazy, L. 1984. Studies on ether phospholipids: II. Comparative composition of various tissues from human, rat and guinea pig. Biochim. Biophys. Acta 793:221-231.
30. Strosznajder, J., Radominska-Pyrek, A., Lazarewicz, J., and Horrocks, L. A. 1977. Synthesis in vitro of 1-alkyl-2-acyl- and 1,2-diacly-SN-glycero-phosphorylcholines and ethanolamines by neuronal, glial and synaptosomal fractions from adult rabbit brain. Bull. Acad. (Paris) XXV: 363-370.
31. Vance, D. E., and Vance, J. (eds.) 1996. Biocehmistry of Lipids, Lipoproteins and Membranes, Elsevier, New York.
32. Miller, S. L., Benjamins, J. A., and Morell, P. 1977. Metabolism of glycerophospholipids of myelin and microsomes in rat brain. J. Biol. Chem. 252:4025-4037.
33. Masuzawa, Y., Sugiura, T., Ishima, Y., and Waku, K. 1984. Turnover rates of the molecular species of ethanolamine plasmalogen of rat brain. J. Neurochem. 42:961-968.
34. Michaelis, T., Wick, M., Fujimori, H., Matsumura, A., and Frahm, J. 1999. Proton MRS of oral creatine supplementation in rats: Cerebral metabolite concentrations and ischemic challenge. NMR Biomed. 12:309-314.
35. O'Donnell, T., Rotzinger, S., Nakashima, T. T., Hanstock, C. C., Ulrich, M., and Silverstone, P. H. 2000. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res. 880:84-91.
36. Harvey, B. H., Brink, C. B., Seedat, S., and Stein, D. J. 2002. Defining the neuromolecular action of myo-inositol application to obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 26:21-32.
37. 13C NMR spectroscopy. Biochim. Biophys. Acta 1580:171-188.
38. Sun, G. Y., and Foudin, L. L. 1985. Phospholipid composition and metabolism in the developing and aging nervous system. Pages 79-135, in Eichberg, J. (Ed.), John Wiley & Sons, New York.
39. 31P NMR in newborn brain. Lancet 1:115.
40. Turner, O., Phoenix, J., and Wray, S. 1994. Developmental and gestational changes of phosphoethanolamine and taurine in rat brain, striated and smooth muscle. Exp. Physiol. 79:681-689.